tiprankstipranks
DRI Healthcare (DE:3IJ0)
FRANKFURT:3IJ0
Germany Market
3IJ0
DRI Healthcare
RESEARCH TOOLSreports

DRI Healthcare (3IJ0) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

3IJ0 Analyst Ratings

Strong Buy
3Ratings
Strong Buy
3 Buy
0 Hold
0 Sell
Based on 3 analysts giving stock ratings to
DRI
Healthcare
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

3IJ0 Stock 12 Month Forecast

Average Price Target

€13.12
▲(35.14% Upside)
Based on 3 Wall Street analysts offering 12 month price targets for DRI Healthcare in the last 3 months. The average price target is €13.12 with a high forecast of €14.15 and a low forecast of €12.30. The average price target represents a 35.14% change from the last price of €9.71.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"€6","15":"€15","8.25":"€8.25","10.5":"€10.5","12.75":"€12.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":14.14741224,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€14.15</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.12223744,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€13.12</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.3020976,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€12.30</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,8.25,10.5,12.75,15],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.092,10.403954787692308,10.715909575384616,11.027864363076922,11.33981915076923,11.651773938461538,11.963728726153846,12.275683513846154,12.587638301538462,12.89959308923077,13.211547876923078,13.523502664615384,13.835457452307692,{"y":14.14741224,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.092,10.325095187692309,10.558190375384616,10.791285563076924,11.02438075076923,11.257475938461539,11.490571126153846,11.723666313846154,11.95676150153846,12.18985668923077,12.422951876923076,12.656047064615384,12.889142252307693,{"y":13.12223744,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.092,10.262007507692308,10.432015015384616,10.602022523076924,10.772030030769232,10.94203753846154,11.112045046153845,11.282052553846153,11.452060061538461,11.622067569230769,11.792075076923076,11.962082584615384,12.132090092307692,{"y":12.3020976,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.796,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.656,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.089,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.12,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.366,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.664,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.696,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.26,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.418,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.936,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.931,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.785,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.092,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€14.15Average Price Target€13.12Lowest Price Target€12.30
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on DE:3IJ0
Justin Keywood
Stifel Nicolaus
Stifel Nicolaus
€14.15
Buy
45.70%
Upside
Reiterated
06/12/26
DRI Healthcare (DHT.UN) Gets a Buy from Stifel Nicolaus
CIBC Analyst forecast on DE:3IJ0
Erin Kyle
CIBC
CIBC
€12.3
Buy
26.70%
Upside
Reiterated
05/19/26
CIBC Sticks to Its Buy Rating for DRI Healthcare (DHT.UN)
RBC Capital Analyst forecast on DE:3IJ0
Douglas Miehm
RBC Capital
RBC Capital
€12.92
Buy
33.03%
Upside
Reiterated
05/15/26
RBC Capital Remains a Buy on DRI Healthcare (DHT.UN)
Bloom Burton Analyst forecast on DE:3IJ0
David Martin PhD
Bloom Burton
Bloom Burton
€12.43→€11.69
Buy
20.36%
Upside
Reiterated
07/18/25
DRI Healthcare's Strong Demand and Royalty Income Drive Buy Rating Despite Pricing Pressures
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Stifel Nicolaus Analyst forecast on DE:3IJ0
Justin Keywood
Stifel Nicolaus
Stifel Nicolaus
€14.15
Buy
45.70%
Upside
Reiterated
06/12/26
DRI Healthcare (DHT.UN) Gets a Buy from Stifel Nicolaus
CIBC Analyst forecast on DE:3IJ0
Erin Kyle
CIBC
CIBC
€12.3
Buy
26.70%
Upside
Reiterated
05/19/26
CIBC Sticks to Its Buy Rating for DRI Healthcare (DHT.UN)
RBC Capital Analyst forecast on DE:3IJ0
Douglas Miehm
RBC Capital
RBC Capital
€12.92
Buy
33.03%
Upside
Reiterated
05/15/26
RBC Capital Remains a Buy on DRI Healthcare (DHT.UN)
Bloom Burton Analyst forecast on DE:3IJ0
David Martin PhD
Bloom Burton
Bloom Burton
€12.43→€11.69
Buy
20.36%
Upside
Reiterated
07/18/25
DRI Healthcare's Strong Demand and Royalty Income Drive Buy Rating Despite Pricing Pressures
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering DRI Healthcare

3 Months
Justin KeywoodStifel Nicolaus
Success Rate
17/27 ratings generated profit
63%
Average Return
+2.66%
Copying Justin Keywood's trades and holding each position for 3 Months would result in 62.96% of your transactions generating a profit, with an average return of +2.66% per trade.
1 Year
Douglas MiehmRBC Capital
Success Rate
27/33 ratings generated profit
82%
Average Return
+29.01%
Copying Douglas Miehm's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +29.01% per trade.
2 Years
Douglas MiehmRBC Capital
Success Rate
33/33 ratings generated profit
100%
Average Return
+50.11%
Copying Douglas Miehm's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +50.11% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

3IJ0 Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
3
3
6
10
9
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
6
10
9
In the current month, 3IJ0 has received 9 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 3IJ0 average Analyst price target in the past 3 months is 13.12.
Each month's total comprises the sum of three months' worth of ratings.

3IJ0 Financial Forecast

3IJ0 Earnings Forecast

Next quarter’s earnings estimate for 3IJ0 is €0.48 with a range of €0.38 to €0.55. The previous quarter’s EPS was €0.58. 3IJ0 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 3IJ0 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 3IJ0 is €0.48 with a range of €0.38 to €0.55. The previous quarter’s EPS was €0.58. 3IJ0 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 3IJ0 has Performed in-line its overall industry.

3IJ0 Sales Forecast

Next quarter’s sales forecast for 3IJ0 is €40.39M with a range of €38.38M to €41.95M. The previous quarter’s sales results were €39.96M. 3IJ0 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 3IJ0 has Performed in-line its overall industry.
Next quarter’s sales forecast for 3IJ0 is €40.39M with a range of €38.38M to €41.95M. The previous quarter’s sales results were €39.96M. 3IJ0 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 3IJ0 has Performed in-line its overall industry.

3IJ0 Stock Forecast FAQ

What is DE:3IJ0’s average 12-month price target, according to analysts?
Based on analyst ratings, DRI Healthcare’s 12-month average price target is 13.12.
    What is DE:3IJ0’s upside potential, based on the analysts’ average price target?
    DRI Healthcare has 35.14% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is DRI Healthcare a Buy, Sell or Hold?
          DRI Healthcare has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
            What is DRI Healthcare’s share price target?
            The average share price target for DRI Healthcare is 13.12. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €14.15 ,and the lowest forecast is €12.30. The average share price target represents 35.14% Increase from the current price of €9.71.
              What do analysts say about DRI Healthcare?
              DRI Healthcare’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
                How can I buy shares of DRI Healthcare?
                To buy shares of DE:3IJ0, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.